Mixed Data For Merck KGaA's Disease-Modifying OA Drug

German firm looking to partner sprifermin

 
• By Kevin Grogan

Sprifermin could be the first drug to affect the underlying disease process in osteoarthritis but data show no significant improvement in symptoms.

Knee_Pain
10% of Americans over 60 years experience knee pain related to OA • Source: Shutterstock

More from Immunological

More from Therapy Areas